Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04323592

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:40.552787+00:00

Published At

2020-06-04T00:00:00+00:00

Record Updated At

2020-06-24

Results Posted At

2020-06-04

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Severe Acute Respiratory Syndrome (SARS) Pneumonia", "Coronavirus Infections", "ARDS, Human"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2020-06-24"

protocolSection.identificationModule.nctId

"NCT04323592"

protocolSection.identificationModule.officialTitle

"Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2020-06-04"

Study condition terms

• Severe Acute Respiratory Syndrome (SARS) Pneumonia (protocolSection.conditionsModule.conditions)
• Coronavirus Infections (protocolSection.conditionsModule.conditions)
• ARDS, Human (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.